Literature DB >> 25658537

Atypical presentation in adults in the largest community outbreak of leishmaniasis in Europe (Fuenlabrada, Spain).

L Horrillo1, J V San Martín2, L Molina3, E Madroñal4, B Matía4, A Castro4, J García-Martínez3, A Barrios2, N Cabello2, I G Arata3, J M Casas4, J M Ruiz Giardin2.   

Abstract

Since 2009, the largest reported outbreak of leishmaniasis by Leishmania infantum in Europe was reported in Fuenlabrada, Spain. In our hospital, 90 adults with localized leishmanial lymphadenopathy (LLL) or visceral leishmaniasis (VL) were treated during this outbreak; 72% were men, and the mean age was 46.2 years (range 15-95 years). A total of 17 cases (19%) were LLL, an atypical form with isolated lymphadenopathies without other symptoms. All LLL cases occurred in immunocompetent subjects, and only one subject (6%) was a native of sub-Saharan Africa. Diagnosis was performed by fine needle aspiration cytology of the lymphadenopathy. Serology was negative in 38%. LLL outcomes at 6 months were benign, even with doses of liposomal amphotericin B that were often lower (10 mg/kg) than those recommended for VL in Mediterranean areas. A total of 73 subjects (81%) presented with typical VL; 66% of this group were immunocompetent, and 50% of those who were immunocompetent were descendants of natives of sub-Saharan Africa. The rK39 test and polymerase chain reaction were the most useful tests for confirmation of the diagnosis. An initial response to treatment was observed in 99% of cases, and relapses occurred in 14% of cases. Leishmaniasis should be included in the differential diagnosis of isolated lymphadenopathies in endemic areas. LLL could be considered a more benign entity, one different than VL, and less aggressive management should be studied in future investigations.
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug therapy; Leishmania infantum; leishmaniasis; localized leishmanial lymphadenopathy; neglected diseases; outbreak; serologic tests; signs and symptoms; visceral

Mesh:

Year:  2014        PMID: 25658537     DOI: 10.1016/j.cmi.2014.10.017

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

1.  Androgen-dependent immune modulation in parasitic infection.

Authors:  Julie Sellau; Marie Groneberg; Hannelore Lotter
Journal:  Semin Immunopathol       Date:  2018-10-23       Impact factor: 9.623

2.  Environmental Factors as Key Determinants for Visceral Leishmaniasis in Solid Organ Transplant Recipients, Madrid, Spain.

Authors:  Nerea Carrasco-Antón; Francisco López-Medrano; Mario Fernández-Ruiz; Eugenia Carrillo; Javier Moreno; Ana García-Reyne; Ana Pérez-Ayala; María Luisa Rodríguez-Ferrero; Carlos Lumbreras; Rafael San-Juan; Jorge Alvar; José María Aguado
Journal:  Emerg Infect Dis       Date:  2017-07       Impact factor: 6.883

3.  Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain.

Authors:  Mathieu Bangert; María D Flores-Chávez; Ivonne P Llanes-Acevedo; Carolina Arcones; Carmen Chicharro; Emilia García; Sheila Ortega; Javier Nieto; Israel Cruz
Journal:  PLoS Negl Trop Dis       Date:  2018-03-01

4.  Acute liver failure due to visceral leishmaniasis in Barcelona: a case report.

Authors:  Iratxe Martinez de Narvajas; Alba Díaz; Octavio Bassegoda; Adriá Carpio; Carla Fuster; María Eugenia Valls; Miriam J Alvarez-Martínez; Carolina García-Vidal; Alejandro Soriano; José Antonio Martínez; Juan Ambrosioni
Journal:  BMC Infect Dis       Date:  2019-10-22       Impact factor: 3.090

5.  Species identification and phylogenetic analysis of Leishmania isolated from patients, vectors and hares in the Xinjiang Autonomous Region, The People's Republic of China.

Authors:  Yun-Fu Chen; Li-Fu Liao; Na Wu; Jiang-Mei Gao; Peng Zhang; Yan-Zi Wen; Geoff Hide; De-Hua Lai; Zhao-Rong Lun
Journal:  PLoS Negl Trop Dis       Date:  2021-12-17

6.  Insights on adaptive and innate immunity in canine leishmaniosis.

Authors:  Shazia Hosein; Damer P Blake; Laia Solano-Gallego
Journal:  Parasitology       Date:  2016-04-20       Impact factor: 3.234

7.  A case report of isolated lymphadenopathy revealing localized leishmanial lymphadenopathy in an asthenic 25-year-old man.

Authors:  Quentin Hurlot; Judith Fillaux; Camille Laurent; Antoine Berry; Paul Hofman; Bruno Marchou; Pierre Delobel; Pierre Brousset; Guillaume Martin-Blondel
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Cutaneous Leishmaniasis - A Case Series from Dresden.

Authors:  Uwe Wollina; André Koch; Claudio Guarneri; Georgi Tchernev; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-10

9.  Cellular Markers of Active Disease and Cure in Different Forms of Leishmania infantum-Induced Disease.

Authors:  Laura Botana; Belén Matía; Juan V San Martin; Alberto Romero-Maté; Alicia Castro; Laura Molina; Laura Fernandez; Ana Ibarra-Meneses; Marta Aguado; Carmen Sánchez; Luis Horrillo; Carmen Chicharro; Javier Nieto; Sheila Ortega; José Manuel Ruiz-Giardin; Eugenia Carrillo; Javier Moreno
Journal:  Front Cell Infect Microbiol       Date:  2018-11-13       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.